We are live on ! Find out more
ME

McIlrath & Eck Portfolio holdings

AUM $1.35B
1-Year Est. Return 15.78%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+15.78%
3 Year Est. Return
+43.95%
5 Year Est. Return
+48.52%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$19.1M
Cap. Flow
+$8.01M
Cap. Flow %
3.84%
Top 10 Hldgs %
84.52%
Holding
684
New
34
Increased
115
Reduced
75
Closed
28

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.95M
2
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$1.26M
3
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$489K
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$462K
5
PCAR icon
PACCAR
PCAR
+$220K

Top Sells

Rank Stock Value
1
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$452K
2
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$242K
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$74.9K
4
UMH
UMH Properties
UMH
+$52.6K
5
MPC icon
Marathon Petroleum
MPC
+$51.4K

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.86%
2 Technology 11.12%
3 Financials 2.19%
4 Communication Services 1.63%
5 Consumer Discretionary 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
51
Walmart Inc
WMT
$845B
$187K 0.09%
4,710
+1,770
+60% +$70.3K
BMY icon
52
Bristol-Myers Squibb
BMY
$130B
$176K 0.08%
2,738
+488
+22% +$27.9K
KO icon
53
Coca-Cola
KO
$377B
$175K 0.08%
3,170
+956
+43% +$51.4K
ABT icon
54
Abbott
ABT
$175B
$162K 0.08%
1,862
+93
+5% +$7.79K
MRK icon
55
Merck
MRK
$361B
$162K 0.08%
1,871
+724
+63% +$59.5K
PFE icon
56
Pfizer
PFE
$158B
$154K 0.07%
4,147
+447
+12% +$15.9K
CB icon
57
Chubb
CB
$131B
$137K 0.07%
881
-19
-2% -$2.91K
BP icon
58
BP
BP
$116B
$136K 0.07%
3,612
+1,510
+72% +$57.3K
SRE icon
59
Sempra
SRE
$53.6B
$135K 0.06%
1,786
+6
+0.3% +$440
VGSH icon
60
Vanguard Short-Term Treasury ETF
VGSH
$34.5B
$135K 0.06%
2,215
– –
AGN
61
DELISTED
Allergan plc
AGN
$132K 0.06%
688
– –
TJX icon
62
TJX Companies
TJX
$137B
$131K 0.06%
2,143
+1
+0% +$59
AIG icon
63
American International
AIG
$39.3B
$129K 0.06%
2,519
– –
MO icon
64
Altria Group
MO
$115B
$128K 0.06%
2,556
+1,032
+68% +$48.7K
GLD icon
65
SPDR Gold Trust
GLD
$147B
$125K 0.06%
874
-61
-7% -$8.52K
FFTY icon
66
CapForce IBD 50 ETF
FFTY
$76.2M
$121K 0.06%
3,479
– –
MELI icon
67
Mercado Libre
MELI
$91.7B
$118K 0.06%
206
+56
+37% +$31K
PYPL icon
68
PayPal
PYPL
$45.5B
$117K 0.06%
1,079
+299
+38% +$31.2K
BKLN icon
69
Invesco Senior Loan ETF
BKLN
$6.79B
$116K 0.06%
5,100
-694
-12% -$15.7K
XOM icon
70
ExxonMobil
XOM
$666B
$115K 0.06%
1,649
-67
-4% -$4.63K
CMCSA icon
71
Comcast
CMCSA
$82.6B
$113K 0.05%
2,521
– –
CVX icon
72
Chevron
CVX
$413B
$113K 0.05%
934
-31
-3% -$3.65K
PSX icon
73
Phillips 66
PSX
$107B
$110K 0.05%
985
+284
+41% +$31.9K
JPM icon
74
JPMorgan Chase
JPM
$923B
$106K 0.05%
760
-41
-5% -$5.26K
SYY icon
75
Sysco
SYY
$37.8B
$105K 0.05%
1,225
– –
1 2
3
4 5

Similar funds

MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
LWL
Leo Wealth LLC Hurst, Texas $1.38B AUM 17.29% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
VIP
Vantage Investment Partners Kansas City, Missouri $1.45B AUM 18.96% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

McIlrath & Eck's Q4 2019 Portfolio in Review

As of Q4 2019, McIlrath & Eck held 684 positions worth $208M, up 10% from $189M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

McIlrath & Eck deployed $8.01M of net new capital in Q4 2019, opening 34 new positions and adding to 115 existing holdings. Its largest new stake was iShares Biotechnology ETF: 512 shares worth $62K.

By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, down from 81% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $452K trimmed.

  • McIlrath & Eck's largest Q4 2019 buy was iShares Biotechnology ETF: 512 shares worth $62K.
  • McIlrath & Eck added most to Microsoft in Q4 2019, an estimated $3.95M increase.
  • McIlrath & Eck's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $452K.
  • McIlrath & Eck fully exited Celgene Corp in Q4 2019, selling an estimated $48K.
  • McIlrath & Eck's ten largest holdings make up 85% of its $208M portfolio in Q4 2019.
  • McIlrath & Eck opened 34 new positions and closed 28 in Q4 2019.
  • McIlrath & Eck's portfolio value rose 10% quarter-over-quarter to $208M.

Based on McIlrath & Eck's 13F filing for Q4 2019, filed 11 Feb 2020.